2 momentum stocks with excellent growth potential

There are plenty of brilliant growth stars ripping higher at the moment. Royston Wild reveals two of the best.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Horizon Discovery (LSE: HZD) has been a pretty impressive performer in recent sessions, its share value rising 7% in the days to the run-up to today’s half-year report. But investor appetite has failed to carry through on the back of the numbers, the stock last dealing fractionally lower in Tuesday’s session.

But I for one am pretty darn chipper over the pharma play’s investment outlook, even if the market remains less than convinced.

Horizon Discovery announced that group revenues soared 19% during the six months to June, to £12.1m. Sales at its Products division increased 10% year-on-year to £5.3m, while over at Services, revenues leapt 30% to £6.8m.

On top of this, the gene editing specialist expects to gobble up future R&D milestones of up to £208m plus future product royalties from its Research Biotech arm, it said.

For the full fiscal year, Horizon Discovery expects the historical second half weighting (around 60% of sales are sourced during July-December), combined with its strong order book, to help generate organic revenues of between £30m and £33m.

The right medicine

It should come as no surprise that Darrin Disley, chief executive of Horizon, took a cheery tone on the back of the results, commenting: “We are very pleased with our progress in the first half of 2017, delivering consistent strong growth as the business continues to scale, and significant margin improvements as steps taken in 2016 to improve operational efficiencies bear fruit.” Gross margins expanded to 64% in the first half from 48% a year earlier.

And Disley lauded the recent $85m acquisition of Dharmacon in particular, saying that the move will “[create] a business which is the global leader in the application of both gene modulation and gene editing technologies.”

The City certainly believes in its hot revenues outlook and expects the business to end its long run of losses from next year onwards. It is predicted to flip from a loss of 3.7p per share in 2017 to earnings of 0.5p in 2018.

A forward P/E ratio of 478 times for next year may be unappealing for many investors. But for patient share selectors, this heady paper valuation may be worth swallowing for the prospect of blockbuster earnings growth in the years ahead.

Bet on this beauty?

GVC Holdings (LSE: GVC) is another London stock predicted to switch back into the black pretty soon.

In 2017 the abacus bashers are anticipating earnings of 62.4 euro cents per share, moving from the losses of 51 cents last year. And a further improvement, to 74.4 cents, is forecast for next year.

This shouldn’t come as a shock as the scale benefits created by the bwin.party acquisition last year, allied to its improving territorial diversification, bear fruit. Net gaming revenues at the gambling giant ripped 25% higher between January and June to €486.2m, a result that saw adjusted pre-tax profit double to €101.9m.

Despite GVC Holdings soaring 31% since the start of 2017, it still trades on a very attractive forward P/E ratio of 15.3 times. I reckon this is terrific value given the company’s colossal revenues opportunities.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended GVC Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »